美國最大製藥公司分別按照年收入和市值排名,其差異應該對選股有幫助:

本帖於 2025-05-08 17:54:44 時間, 由普通用戶 BigMountain6 編輯

所有跟帖: 

有意思。謝謝分享。市值和收入不成正比有很多因素。 -gastank1289- 給 gastank1289 發送悄悄話 (162 bytes) () 05/08/2025 postreply 17:44:10

What if using TTM revenue? Or even better FTM rev estimate? -三心三意- 給 三心三意 發送悄悄話 三心三意 的博客首頁 (0 bytes) () 05/08/2025 postreply 18:10:06

Certainly FTM works better, however -BigMountain6- 給 BigMountain6 發送悄悄話 (115 bytes) () 05/08/2025 postreply 19:26:22

That should be reflected in revenue, margin, and earning -三心三意- 給 三心三意 發送悄悄話 三心三意 的博客首頁 (155 bytes) () 05/08/2025 postreply 19:34:45

Indicator PEG is definitely excellent, but difficult to be ~ -BigMountain6- 給 BigMountain6 發送悄悄話 (114 bytes) () 05/09/2025 postreply 05:23:13

PFE's 5 years expected PEG is 0.58 vs. LLY 1.12. -ht842- 給 ht842 發送悄悄話 (36 bytes) () 05/09/2025 postreply 05:38:13

請您先登陸,再發跟帖!